Immunome, Inc.
Senior Oncology Account Manager – Anticipated Opening (Product Launch)
Company Overview
As we continue to advance our commercial build, we are preparing for the future addition of field sales personnel to support our growing organization. In advance of formal job postings expected to go live in the coming months, we are beginning to identify and gather information from prospective candidates who meet our qualifications and may be interested in joining our Commercial team. The final number of sales positions and specific geographic territories are still being determined; however, engaging with interested candidates now will help streamline our recruiting efforts and allow us to more efficiently connect qualified individuals with relevant opportunities once positions are formally posted.
We are particularly interested in experienced oncology sales professionals with a demonstrated track record of strong performance, including experience launching oncology therapeutics for rare cancer subtypes and promoting oral oncology agents. If you are interested in being considered for future opportunities, please submit your resume and provide some baseline information about your experiences.
We strongly encourage you to monitor our Career Page for active postings and apply to roles that are a good match for your experience, skills, and interests.
E/E/O
Immunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
E-Verify
Immunome, Inc. is a participant in E-Verify. Please review the following notices: E-Verify Participation Poster | Right to Work Poster (English) | Right to Work Poster (Spanish).
Similar Jobs
What you need to know about the Los Angeles Tech Scene
Key Facts About Los Angeles Tech
- Number of Tech Workers: 375,800; 5.5% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Snap, Netflix, SpaceX, Disney, Google
- Key Industries: Artificial intelligence, adtech, media, software, game development
- Funding Landscape: $11.6 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Strong Ventures, Fifth Wall, Upfront Ventures, Mucker Capital, Kittyhawk Ventures
- Research Centers and Universities: California Institute of Technology, UCLA, University of Southern California, UC Irvine, Pepperdine, California Institute for Immunology and Immunotherapy, Center for Quantum Science and Engineering


